BioSpace News Archive

Deals

Aptorum Group Limited Announces Repurchase of USD13,500,000 Outstanding Convertible Bonds Due 2019

Aptorum Group Limited announced that the Company, in a privately-negotiated transaction, repurchased all outstanding US$13,500,000 in aggregate principal amount of the 8.00 per cent.

April 24, 2019
·
4 min read
BioForest

New TFAH Report: Persistent Underfunding of America’s Public Health System Makes the Nation Vulnerable and Puts Lives at Risk

Funding for public health programs via the CDC budget decreased by 10 percent over the last decade while public health risks grew

April 24, 2019
·
4 min read
Deals

Axonics® to Report First Quarter 2019 Financial Results and Host a Conference Call on May 8

Axonics Modulation Technologies, Inc. announced that it will release financial results for the first quarter of 2019 and provide an update on operations and FDA regulatory status after the market closes on Wednesday, May 8, 2019.

April 24, 2019
·
1 min read
FDA

Knopp Biosciences Receives FDA Orphan Drug Designation for Dexpramipexole for Treatment of Hypereosinophilic Syndrome

Knopp Biosciences LLC announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to dexpramipexole, its oral drug candidate for the treatment of hypereosinophilic syndrome.

April 24, 2019
·
3 min read
BioMidwest

Blue Cross Blue Shield Association Study Finds Millennials are Less Healthy than Generation X Were at the Same Age

One in three millennials do not have a primary care physician and are less likely to seek preventative care on a regular basis

April 24, 2019
·
4 min read
Drug Development

GT Biopharma (GTBP) Announces the Elimination of HIV Infected Cells Using its Tri-Specific Killer Engagers (TriKEs) in Preclinical Testing at the University of Minnesota

GT Biopharma, Inc announced its Tri-Specific Killer Engager can target HIV infected cells in University of Minnesota’s preclinical testing.

April 24, 2019
·
9 min read
Pharm Country

CytoSorbents Highlights the 6th International CytoSorb Users’ Meeting and Recent Activities at the 2019 ISICEM and EuroELSO Conferences

CytoSorbents Corporation shares highlights from the recent 6th International CytoSorb Users’ Meeting and the Satellite Symposium at the 39th International Symposium on Intensive Care and Emergency Medicine in Brussels, Belgium, and the 8th Annual EuroELSO 2019 Conference held recently in Barcelona, Spain.

April 24, 2019
·
12 min read
Drug Development

Arrowhead Begins Triple Combination Cohort in Chronic HBV Patients and Earns $25 Million Milestone Payment from Janssen

Arrowhead Pharmaceuticals Inc. announced that it has begun dosing in a new triple combination cohort (cohort 12) that includes JNJ-3989 (formerly ARO-HBV) and additional undisclosed agents selected by Janssen Pharmaceuticals, Inc. in its ongoing Phase 1/2 study (AROHBV1001) in patients with chronic hepatitis B virus (HBV).

April 24, 2019
·
4 min read
Business

BurstIQ Signs Strategic Partnership with International Trade Administration (ITA) to Support Blockchain Healthcare and FinTech Initiatives

BurstIQ is the first blockchain company to join the ITA Strategic Partnership Program

April 24, 2019
·
2 min read
BioMidwest

More than 4 in 10 Americans Live with Unhealthy Air; Eight Cities Suffered Most Polluted Air Ever Recorded

American Lung Association’s 20th annual ‘State of the Air’ report sounds the alarm on worsened air quality driven by climate change, placing health and lives at risk

April 24, 2019
·
8 min read